TRDA SG&A Expense Growth
Entrada Therapeutics Inc · SG&A Expense Growth
TRDA SG&A Expense Growth
Latest reported6.72%period ending
TRDA FY SG&A Growth (YoY) (0.00% → 6.72%)
Latest values, visible window
High-resolution chart · PNG
TRDA sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 6.7204% | |
| 19.1199% | |
| 5.3918% | |
| 101.5591% | |
| 190.1508% | |
| 45.2051% | |
| 0% |